Back
Disc Medicine Vs. Amylyx Pharmaceuticals Industry Stock Comparison
Buy
70
IRON
Disc Medicine
Last Price:
32.06
Seasonality Move:
-1.8%
Sell
26
AMLX
Amylyx Pharmaceuticals
Last Price:
1.82
Seasonality Move:
101.62%
Buy
70
Disc Medicine (IRON)
is a Buy
Is Disc Medicine a Buy, Sell or Hold?
- The current Disc Medicine [IRON] share price is $31.86. The Score for IRON is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- IRON is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $1.82. The Score for AMLX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IRON Stock Price Chart
What is Disc Medicine's stock price today?
-
The Disc Medicine share price today is $31.86
The current trend is relatively stagnant and IRON is experiencing selling pressure, which indicates risk of future bearish movement.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $1.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing selling pressure, which indicates risk of future bearish movement.
IRON Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.13 | Sell |
Relative Strength Index (14 RSI): | 45.82 | Sell |
Chaikin Money Flow: | -275057 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.87 - 31.13) | Buy |
Bollinger Bands (100): | (36.52 - 69.36) | Sell |
AMLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.5 | Sell |
Relative Strength Index (14 RSI): | 29.25 | Sell |
Chaikin Money Flow: | -1095885 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.81 - 2.05) | Sell |
Bollinger Bands (100): | (2.59 - 16.49) | Sell |
IRON Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.67 | Buy |
20-day SMA: | 29.14 | Buy |
50-day SMA: | 41.32 | Sell |
200-day SMA: | 51.98 | Sell |
8-day EMA: | 30.76 | Buy |
20-day EMA: | 31.25 | Buy |
50-day EMA: | 38.92 | Sell |
200-day EMA: | 47.3 | Sell |
AMLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.88 | Sell |
20-day SMA: | 1.9 | Sell |
50-day SMA: | 3.07 | Sell |
200-day SMA: | 13.6 | Sell |
8-day EMA: | 1.86 | Sell |
20-day EMA: | 2.09 | Sell |
50-day EMA: | 4.27 | Sell |
200-day EMA: | 12.6 | Sell |
Disc Medicine Earnings Growth & IRON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.12 per share, a decrease this year of $1.75 per share, and a decrease next year of $0.45 per share.
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.01 per share, an increase next quarter of $0.14 per share, a decrease this year of $2.19 per share, and a decrease next year of $0.28 per share.
Disc Medicine Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amylyx Pharmaceuticals Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |